Neurocrine Biosciences, Inc. (NBIX)
Analyst consensus, price target and coverage. 27 analysts, updated daily.
Analyst votes
How the ratings break down
27 ratings on record
- Strong Buy4
- Buy19
- Hold4
- Underperform0
- Sell0
Price targets
Where the estimates sit
How far apart analysts are on this name.
Low 190.00
Mean 213.13
High 249.00
share price 156.49 mean target 213.13. Analysts are spread 31% apart, and the share price sits below every target on record.
Most recent action
Last rating change
| Firm | Canaccord Genuity |
|---|---|
| Date | 2026-08-03 |
| Change | Buy → Buy |
Size and liquidity
Key statistics
| Market cap | 15.91B USD |
|---|---|
| Cap class | Large |
| Average volume | 1,243,166 |
| Dollar volume per day | 194.5M |
| Liquidity | High |
| Internal score | 84.5 / 100 |
Recommendation
How it moved, scan by scan
2 scans on record
| Scan | Move | Consensus | Score | SB | Buy | Hold | Und | Sell |
|---|---|---|---|---|---|---|---|---|
| 2026-08-13 | = | Strong Buy | 2.00 | 4 | 19 | 4 | 0 | 0 |
| 2026-08-11 | · | Strong Buy | 2.00 | 4 | 19 | 4 | 0 | 0 |
Score is the analyst average on Yahoo's scale, where 1 is Strong Buy and 5 is Sell, so a falling number means the view improved. ▲ more positive, ▼ more negative, = unchanged.
History
Price target over time
2 daily points recorded
| Date | Price | Target | Upside | Consensus |
|---|---|---|---|---|
| 2026-08-13 | 156.49 | 213.13 | +36.2% | Strong Buy |
| 2026-08-11 | 162.65 | 213.13 | +31.0% | Strong Buy |
Similar coverage
Comparable large-cap names
Closest upside among companies of the same size.